GlaxoSmithKline suffers a loss after charges - MarketWatch
Reuters IndiaGlaxoSmithKline suffers a loss after chargesMarketWatchAnnual comparisons were also hurt, as the company didn't have the benefit of a boost in sales of pandemic flu drugs. A reduction in its Avandia sales ...Some Paxil lawsuits settled by GlaxoPhiladelphia Inquirerall 180 news articles��
Blog Content
No comments:
Post a Comment